JPT Peptide Technologies’ cover photo
JPT Peptide Technologies

JPT Peptide Technologies

Biotechnology Research

JPT is the Peptide Expert!

About us

We are the Peptide Experts! JPT has a large peptide synthesis capacity, providing over 1 million peptides per year. We offer all possible peptide modifications such as macrocyclic peptides, phosphorylated peptides, labeled and tagged peptides, radioligands, isotope labeling and more. Made in Germany Global Support More than 20 Years of Expertise Ethical, Environmental & Health Standards Portfolio: Custom Peptides Our patented technologies in peptide libraries, pools, microarrays, and micro-scale synthesis set us apart as a leader in the field. From micro to large-scale synthesis, our state-of-the-art labs in Germany deliver peptides tailored to your needs. Modified Peptides We produce modified peptides such as long and stapled peptides, dyes, labeled and biotinylated peptides, PTMs, unique building blocks, conjugations, macrocyclic peptides and more. PepMix Peptide Pools Peptide pools for antigen-specific T-cell stimulation in immune monitoring, assay control, cell therapy development, T-cell expansion etc. In addition to custom PepMix peptide pools we have more than 500 PepMixes in stock, for example: Control Pools: CEFX, CEF, Actin, CMV pp65 … Viral Proteins of EBV, SARS-CoV-2, CMV, VZV, HPV … TAA: Prame, NY-ESO-1, MART-1, MAGE A … Clinical Peptides & Pools Our resulting Clinical Grade Peptides have been approved for a variety of clinical applications including immunotherapy and vaccine development, immune monitoring, and clinical proteomics. Please visit our website for more information! JPT Peptide Technologies GmbH Management: Aurélien Claeyssen, Jens Holstein, Dr. Sierk Poetting Volmerstr. 5 D- 12489 Berlin T: +49 30 6392 5500 peptide@jpt.com https://www.jpt.com/ Registration Court: Berlin / Amtsgericht Charlottenburg, HRB 92692 VAT identification number: DE 814044483 Imprint: https://www.jpt.com/support-contact/corporate/imprint/ Privacy Policy: https://www.jpt.com/support-contact/corporate/privacy-policy/

Website
https://www.jpt.com/
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Berlin
Type
Privately Held
Founded
2004
Specialties
Peptide Synthesis, Peptide Microarrays, Peptide Libraries, Peptide Pools, Proteotypic Peptides, Stable Isotope labeled peptides, Immunotherapy, Clinical Peptides, Peptide Analyses, Custom Peptides, Macrocyclic Peptides, Made in Germany, DOTA peptides, Radioligands, Cell penetrating peptides, T cell controls, and ELISpot Service

Locations

  • Primary

    JPT Peptide Technologies GmbH

    Volmerstraße 5

    Berlin, 12489, DE

    Get directions

Employees at JPT Peptide Technologies

Updates

  • 𝗧𝗵𝗶𝘀 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗹𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲! 𝗦𝗶𝗴𝗻 𝘂𝗽 𝗻𝗼𝘄! Join us for the free ELISpot Workshop in Munich. Registration deadline is Monday, March 31st. Scan the QR code, or sign up via the link in our comments. For questions reach out to Michael Drosch or Sylvia Janetzki! Merck Group, ZellNet Consulting, Mabtech, BioNTech SE #myjpt #elispot #workshop #seminar #biontech

  • 𝗦𝗲𝗮𝘀𝗼𝗻𝗮𝗹 𝗣𝗲𝗽𝗠𝗶𝘅™ 𝗳𝗼𝗿 𝗦𝗔𝗥𝗦2 & 𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘇𝗮 & 𝗡𝗼𝗿𝗼𝘃𝗶𝗿𝘂𝘀! We made it through winter and seasonal infection rates are at their peak in the northern hemisphere. Monitoring Influenza and SARS-CoV-2 infections while developing effective vaccines and cell therapies is imperative to minimize the impact of the diseases. Check out our New PepMix™ Peptide Pools via the link below! #norovirus #sars2 #Influenza #pepmix #seasonalinfections #myjpt

    • No alternative text description for this image
  • 𝗜𝘁 𝗶𝘀 𝗪𝗼𝗿𝗹𝗱 𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 𝗗𝗮𝘆! One part of managing and preventing the spread of the tuberculosis is scientific innovation into therapy and vaccines. With budget cuts affecting said research, and diagnostic services, disease screenings, and surveillance programs slowing down, the WHO – prior to World Tuberculosis Day – called for more immediate resource investment. Despite great successes of reducing infection and mortality rates since 2000, TB has probably returned to being the world’s leading cause of death from a single infectious pathogen. According to the global tuberculosis report 2024, in August, 6 vaccines were in phase III trials. Moreover, addressing drug resistant TB includes new diagnostic approaches and therapy regimens, on top of implementing already existing strategies to implement care directly to patients. 🏥 💉 We contribute on a small level. 🔍 We provide peptides covering common immune response inducing M. Tuberculosis antigens, either in the form of overlapping PepMix peptide pools or single antigens covering immune-dominant epitopes. 🧫 🦠 𝘊𝘰𝘮𝘦 𝘢𝘯𝘥 𝘧𝘪𝘯𝘥 𝘰𝘶𝘵, 𝘣𝘺 𝘤𝘭𝘪𝘤𝘬𝘪𝘯𝘨 𝘰𝘯 𝘵𝘩𝘦 𝘜𝘙𝘓 𝘪𝘯 𝘰𝘶𝘳 𝘤𝘰𝘮𝘮𝘦𝘯𝘵𝘴. 🔎   #myjpt #worldtuberculosisday #tuberculosis #pepmix  

  • 🔎 𝘞𝘩𝘢𝘵 𝘥𝘰𝘦𝘴 𝘱𝘦𝘱𝘵𝘪𝘥𝘦 𝘱𝘶𝘳𝘪𝘵𝘺 𝘮𝘦𝘢𝘯 𝘢𝘵 𝘑𝘗𝘛?   How to store peptides? How long are they stable? Which quantities can and should i choose? Many questions, many answers! When selecting and customizing your PepMix™ Peptide Pool, you have take many different things into account. Find out what those are in the comment below! #myjpt #pepmix #peptide #protocol

    • No alternative text description for this image
  • 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗝𝗣𝗧'𝘀 𝗡𝗘𝗪 𝗛𝘆𝗱𝗿𝗼𝗴𝗲𝗹 𝗙𝗼𝗿𝗺𝗶𝗻𝗴 𝗣𝗲𝗽𝘁𝗶𝗱𝗲𝘀! We are expanding our range of peptide categories and are pleased to introduce a new product line to our peptide catalog: 𝘏𝘺𝘥𝘳𝘰𝘨𝘦𝘭 𝘍𝘰𝘳𝘮𝘪𝘯𝘨 𝘗𝘦𝘱𝘵𝘪𝘥𝘦𝘴! 🔴 Among other materials, such hydrogels can be formed via the self-assembly or peptides. The creation of such tunable structures come with broad applications in the fields of tissue engineering, drug delivery, wound healing, and regenerative medicine. 🏥 🚑 💊 💉 ✔️ Find out more in the comment below! #hydrogel #peptides #biomaterials #tissueengineering #drugdelivery

    • No alternative text description for this image
  • 𝐈𝐬 𝐲𝐨𝐮𝐫 𝐄𝐋𝐈𝐒𝐩𝐨𝐭 𝐠𝐢𝐯𝐢𝐧𝐠 𝐲𝐨𝐮 𝐭𝐫𝐨𝐮𝐛𝐥𝐞? 😕 👩🏫 We look forward to seeing you at the ELISpot/FluoroSpot Workshop in Munich! Michael Drosch, Sylvia Janetzki, Tyler Sandberg, PhD

    View profile for Sylvia Janetzki

    President, ZellNet Consulting, Inc.

    Don't miss the free Elispot/Fluorospot workshop in Munich on April 2nd. You got the questions? We got the answers! Info below. Registration: https://lnkd.in/eEZ5ee4W

    • No alternative text description for this image
  • 𝗛𝗼𝘄 𝘁𝗼 𝗦𝗣𝗢𝗧 𝘁𝗵𝗲 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲? The ELISpot Resource Group (ERG) organizes a free ELISpot/FluoroSpot workshop to inform you about the ELISpot technique, new developments, and control. The next ELISpot workshop will be hosted by BioNTech SE in Munich on April 2nd. The ERG consists of ELISpot enthusiasts from ZellNet Consulting, Mabtech, Merck Group, and yours truly, JPT Peptide Technologies. We are excited to meet you. So, sign up & let’s connect! Please find the signup link in the comments 💬 👇 #myjpt #elispot #webinar Sylvia Janetzki

    • No alternative text description for this image
  • 𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗼𝗻𝗲?  𝗢𝗻𝗲 𝗺𝗼𝗿𝗲 𝗳𝗿𝗲𝗲 𝗘𝗟𝗜𝗦𝗽𝗼𝘁 𝗪𝗲𝗯𝗶𝗻𝗮𝗿, 𝘁𝗵𝗶𝘀 𝘁𝗶𝗺𝗲 𝗶𝗻 𝗢𝘅𝗳𝗼𝗿𝗱! The ELISpot Resource Group (ERG) regularly organizes free ELISpot/FluoroSpot workshops worldwide to inform about the ELISpot technique, new developments, and control. The ERG consists of ELISpot enthusiasts from ZellNet Consulting, Mabtech, Merck Group, and yours truly, JPT Peptide Technologies. This time, the next ELISpot workshop will be hosted by Jenner Institute in Oxford on April 3rd. We are excited to meet you. So, sign up & connect with Michael Drosch, or Sylvia Janetzki! Please find the signup link in the comments 💬 👇 #myjpt #elispot #webinar

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs